Search

everythinglearnresearchcommunity

for

Search:↓

Men, particularly those with hair loss, are more likely to get the virus, and those with prostate cancer may have milder symptoms. Testosterone's role in the disease is unclear, and the virus doesn't seem to harm male fertility. Women with PCOS might be at higher risk. More research is needed.

Asthma and high testosterone increase Covid-19 severity, while progesterone protects young women.

A CCS patient with severe complications was successfully treated using combined therapies.

Severe male balding may increase the risk of serious COVID-19, and treatments that reduce androgens or block a specific enzyme might help protect these individuals.

Anti-androgens might help reduce COVID-19 severity in men.

The French COVID-19 lockdown caused delays in diagnosing new melanoma cases, making them more severe.

Androgenetic alopecia may increase the severity of COVID-19.

The COVID-19 pandemic led to fewer dermatology patients, more stress-related skin conditions during the crisis, and a rise in contact dermatitis after, with ongoing concerns for public health and treatment delays.

COVID-19 may cause hair loss conditions like alopecia areata and telogen effluvium.

Women with PCOS have a higher risk of severe COVID-19 due to related health issues.

Men and women get COVID-19 at similar rates, but men tend to get sicker and have a higher risk of dying, while women usually have stronger immune responses and vaccine reactions.

Women with PCOS have a higher risk of severe COVID-19 due to related health issues.

Certain genetic variants reduce enzyme activity, contributing to non-classic congenital adrenal hyperplasia.

Antioxidants might help with Long Covid by addressing oxidative stress and nutrient imbalances.

COVID-19 can cause various skin problems, including reactions to protective gear and medication, with different rates reported worldwide, and more research is needed to fully understand these skin issues.

The Gabrin sign may help identify COVID-19 patients at high risk who also have hair loss due to male hormones.

COVID-19 can worsen autoimmune skin diseases and increase their occurrence.

Telogen effluvium is common after symptomatic COVID-19, especially in young females, and may be linked to nutritional deficiencies.

77% of recovered COVID-19 patients in Nepal experienced long-term symptoms like fatigue, hair loss, and breathing issues.

The COVID-19 pandemic did not significantly change stress levels in preschoolers, but higher-income families' children showed higher stress.

Dilated scalp capillaries might be a sign of hair loss related to COVID-19.

Many patients experienced severe hair loss after COVID-19, especially older adults and women.

The Pfizer COVID-19 vaccine may rarely trigger nail psoriasis.

COVID-19 can cause different skin issues, including rashes and hair loss.

Some patients with hair loss after mild COVID-19 had positive tests for certain autoantibodies.

Higher ACE2 levels in certain tissues may worsen COVID-19 in people with other health issues, especially older adults.

The pandemic highlighted the need for accurate information, vaccine development, and adapting to new routines while managing stress and misinformation.

COVID-19 may increase hair loss due to stress and inflammation.

Higher dihydrotestosterone may be linked to more inflammation in COVID-19 patients with low testosterone.